Stock 300765 CSPC INNOVATION PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights CSPC Innovation Pharmaceutical Co., Ltd.

Equities

300765

CNE100003K04

End-of-day quote Shenzhen S.E.
Other stock markets
 03:30:00 28/05/2024 am IST 		5-day change 1st Jan Change
30.39 CNY -1.14% Intraday chart for CSPC Innovation Pharmaceutical Co., Ltd. -5.74% -0.42%
22/04 CSPC Innovation Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
19/04 China's drugmakers can't sell mRNA shots but haven't quit yet RE

Highlights

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
CSPC Innovation Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
China's drugmakers can't sell mRNA shots but haven't quit yet
RE
CSPC Innovation Pharmaceutical Co., Ltd. Approves Cash Dividend for 2023
CI
Tranche Update on CSPC Innovation Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on September 21, 2023.
CI
CSPC Innovation Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for the Year 2023
CI
CSPC Innovation Pharmaceutical's Attributable Profit Rises 4%; Shares Jump 6%
MT
CSPC Innovation Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
CSPC Baike's 2023 Profit Reaches 859 Million Yuan
MT
Tranche Update on CSPC Innovation Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on September 21, 2023.
CI
CSPC Innovation Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Tranche Update on CSPC Innovation Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on September 21, 2023.
CI
CSPC Innovation Pharmaceutical Co., Ltd. announces an Equity Buyback for CNY 421.8 million worth of its shares.
CI
CSPC Innovation Pharmaceutical Co., Ltd. authorizes a Buyback Plan.
CI
CSPC Innovation Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
China’s NMPA Accepts CSPC Pharma’s License Application for Asthma Drug
MT
CSPC Innovation Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Cspc Innovation Pharmaceutical Co., Ltd. Announces Final Dividend on A Shares for the Year 2022, Payable on April 27, 2023
CI
CSPC Innovation Pharmaceutical Co., Ltd. Approves Cash Dividend for 2022
CI
CSPC Innovation Pharmaceutical Co., Ltd. Proposes Final Dividend for 2022
CI
CSPC Innovation Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 300765 Stock
  4. News CSPC Innovation Pharmaceutical Co., Ltd.
  5. Highlights